| 2-[4-(2-Methylpropyl)phenyl] ethanol |
布洛芬EP杂质H |
2143535-25-3 |
| (S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
硼替佐米杂质 |
289472-80-6 |
| N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
289494-16-2 |
| 2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]phenyl-2-propanol |
孟鲁司特钠杂质 |
287930-77-2 |
| Cediranib |
西地尼布 |
288383-20-0 |
| Sorafenib |
索拉非尼 |
284461-73-0 |
| A 286982 |
A 286982 |
280749-17-9 |
| Palonosetron impurity |
(R)-N-(((R)-1,2,3,4-四氢萘-1-基)甲基)奎宁环-3-胺 |
2216746-63-1 |
| SB216763 |
SB216763 |
280744-09-4 |
| Topiroxostat Impurity |
托匹司他杂质 |
2044702-36-3 |
| Etravirine |
依曲韦林 |
269055-15-4 |
| Fosaprepitant dimeglumine |
福沙吡坦二甲葡胺 |
265121-04-8 |
| 2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-yl]propanamide |
奈妥吡坦 |
290297-26-6 |
| NSC-703786 |
4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯胺 |
260443-89-8 |
| Fesoterodinefumarate |
富马酸非索罗定 |
286930-03-8 |
| PELITINIB |
培利替尼 |
257933-82-7 |
| CCG-1423 |
CCG1423 |
285986-88-1 |
| Rucaparib |
鲁卡帕尼 |
283173-50-2 |
| AKT/SKG SUBSTRATE PEPTIDE |
蛋白激酶B(抗原) |
276680-69-4 |
| Vildagliptin |
维格列汀 |
274901-16-5 |
